Teladoc Health, Inc. - Lewisville
Registration 3021611414FEI 3021611414Lewisville, TX
Owner/operator: Teladoc Health, Inc.
- Complaint File Establishment per 21 CFR 820.198
- Develop Specifications But Do Not Manufacture At This Facility
- Manufacture Medical Device
- Repack or Relabel Medical Device
Renewal due by December 31, 2026
Registered through 2026. Renew between October 1 and December 31, 2026, to stay registered for 2027.
90days left in the window
The 2026 window
- Oct 1Window opens91 days left
- Nov 3Where you stand58 days left
- Dec 1Our pay-by date30 days left
- Dec 15Two weeks left16 days left
- Dec 23Holiday week8 days left
- Dec 29Two days left2 days left
- Dec 31Window closes0 days left
- FDA fee, FY2027
- $13,785
- Our pay-by suggestion
- Dec 1
- Listed devices
- 14
- Added, last 12 months
- 6
FDA sets who pays the fee and who may qualify for a waiver; its fee page says so. The fee is paid only on FDA’s own fee site. Never through us. FDA’s fee page
The steps, in order
Pay FDA's annual feeYou
Order and pay the FY2027 establishment fee on FDA's Device Facility User Fee site. FDA emails you a PIN when you order.
FDA: registration and listing payment processWait for the payment confirmation numberYou
FDA emails a Payment Confirmation Number (PCN) once the payment processes, which FDA says typically takes several days. That is why we suggest paying by December 1.
FDA: registration and listing payment processRenew the registration in FDA's systemYou
Sign in to FDA's Unified Registration and Listing System (FURLS), complete the annual registration and apply your PIN and PCN. FDA does not count the registration as complete until both are applied.
FDA: device registration and listingReview every listingYou
In the same window, review each listing on file and report any changes, deletions and new listings. Your Listing Review Sheet puts every listing on one page.
FDA: device registration and listing
Every listed device 14
| Code | Device | Class | Regulation | Premarket |
|---|---|---|---|---|
| PUH | Analyzer, Body Composition, ExemptCardiovascular | Class 2 | 21 CFR 870.2770 | — |
| CGA | Livongo BGMSGlucose Oxidase, Glucose | Class 2 | 21 CFR 862.1345 | K133584 |
| QBJ | Integrated Continuous Glucose Monitoring System, Factory CalibratedClinical Chemistry | Class 2 | 21 CFR 862.1355 | DEN170088 |
| QRL | Multiple Use Blood Lancet For Single Patient Use OnlyGeneral, Plastic SurgeryAdded Jan 14, 2026 | Class 2 | 21 CFR 878.4850 | K220475 |
| QRK | Single Use Only Blood Lancet Without An Integral Sharps Injury Prevention FeatureGeneral, Plastic SurgeryAdded Jan 14, 2026 | Class 2 | 21 CFR 878.4850 | K220475 |
| DXN | System, Measurement, Blood-Pressure, Non-InvasiveCardiovascular | Class 2 | 21 CFR 870.1130 | K131395 |
| DXN | System, Measurement, Blood-Pressure, Non-InvasiveCardiovascular | Class 2 | 21 CFR 870.1130 | K202891 |
| DXN | System, Measurement, Blood-Pressure, Non-InvasiveCardiovascularAdded Dec 11, 2025 | Class 2 | 21 CFR 870.1130 | K241351 |
| NBW | Livongo BGMSSystem, Test, Blood Glucose, Over The Counter | Class 2 | 21 CFR 862.1345 | K133584 |
| NBW | System, Test, Blood Glucose, Over The CounterClinical ChemistryAdded Dec 11, 2025 | Class 2 | 21 CFR 862.1345 | K243060 |
| PHV | Livongo Mobile App Retrospective CGM Data AnalysisContinuous Glucose Monitor Retrospective Data Analysis SoftwareAdded Dec 9, 2025 | Class 1 | 21 CFR 862.2120 | — |
| FRI | Scale, Stand-On, PatientGeneral Hospital | Class 1 | 21 CFR 880.2700 | — |
and 2 more on your full dossier
What changed
- Jan 14, 2026Listing added: QRL — Multiple Use Blood Lancet For Single Patient Use Only (K220475)
- Jan 14, 2026Listing added: QRK — Single Use Only Blood Lancet Without An Integral Sharps Injury Prevention Feature (K220475)
- Dec 11, 2025Listing added: DXN — System, Measurement, Blood-Pressure, Non-Invasive (K241351)
- Dec 11, 2025Listing added: NBW — System, Test, Blood Glucose, Over The Counter (K243060)
- Dec 9, 2025Listing added: PHV — Livongo Mobile App Retrospective CGM Data Analysis
- Jan 14, 2026Listing added: JJX — Single (Specified) Analyte Controls (Assayed And Unassayed)